Trial intelligence / Profile preview

Paclitaxel in Bronchioalveolar Carcinoma

NCT00002972Phase 2Completed

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Jan 1997
Primary completion
Aug 2002
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of paclitaxel in Bronchioloalveolar carcinoma (BAC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 1997; status: completed.

02

Drugs

paclitaxel
03

Conditions

Bronchioloalveolar carcinoma (BAC)

Beyond the preview

Go deeper on NCT00002972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call